approval to build upon its open-label Phase II trial of RECCE ® 327 Topical Gel (R327G) for the treatment of diabetic foot infections (DFI), enabling the enrollment of up to 20 additional patients.

In November 2022, Virginia-based Contraline became the first company to ever implant a male contraceptive gel into humans in a clinical trial. By now, the gel has been implanted into the vas ...

An implantable, non-hormonal male contraceptive has been shown in trials to last for at least two years. The contraceptive, known as Adam, is a water-soluble hydrogel that is implanted in the sperm ...

SYDNEY, April 23, 2025 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (Recce or the Company), a leading developer of a new class of synthetic anti-infectives, today announced it ...

Here’s how it works. The best OBD-II scanners can unlock the secrets of your car, connecting to the onboard computer and giving you access to the information it contains. Whether there's a ...

ASICS is giving fans one last chance to grab the ever-popular ASICS GEL-KAYANO 30 running shoe at a discount before it disappears for good. With the release of the new GEL-KAYANO 31 in June ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Medical device company Contraline became the first to implant a hydrogel-based male contraceptive gel into humans in a clinical trial. Implanted during a noninvasive 10-minute office procedure ...